Article Details

Alector, Inc. SEC 10-K Report - TradingView

Retrieved on: 2025-02-26 21:51:52

Tags for this article:

Click the tags to see associated articles and topics

Alector, Inc. SEC 10-K Report - TradingView. View article details on hiswai:

Excerpt

... monoclonal antibodies, including latozinemab and AL101. New Product Launches: The company is actively developing new therapeutic candidates, such ...

Article found on: www.tradingview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo